MIT Startup Exchange Names Asimov to STEX25
Prestigious program will grow industry partnerships
Cambridge, MA – May 15, 2018.
Asimov, a company that programs living cells with genetic circuits, has been named to STEX25 by the Massachusetts Institute of Technology Startup Exchange (MIT Startup Exchange).
MIT Startup Exchange promotes collaboration and partnerships between more than 1,400 MIT-connected startups and members of the university’s Industrial Liaison Program (ILP). STEX25 comprises 25 industry-ready startups that receive promotion, travel, and advisory support, and are prioritized for meetings with ILP’s 240+ member companies.
“Asimov has deep connections to MIT, so it’s an honor to be named to STEX25. We look forward to growing our relationships with industry partners and connecting with other esteemed startups from the MIT community,” said Alec Nielsen, PhD, Asimov CEO and co-founder. “Our cell programming platform allows us to engineer next-generation therapeutics and create previously impossible biotechnologies. We’re excited to scale our commercial efforts.”
MIT Startup Exchange and the ILP are integrated programs of MIT Corporate Relations.
“Startups selected for STEX25 exhibit the high-caliber talent and cutting-edge technology that are hallmarks of MIT, and feedback from industry partners is that MIT Startup Exchange is one of the most effective filters for emerging tech startups,” said Executive Director of MIT Corporate Relations Karl Koster.
“We are very pleased to have Asimov join STEX25,” said Marcus Dahllöf, MIT Startup Exchange Program Director. “They represent the next generation of life sciences startups emerging from MIT. Life sciences has been a historic strength of MIT, and it’s great to see that represented in STEX25.”
In 2017, Asimov received seed funding in a round led by Andreessen Horowitz, with participation by Data Collective, Pillar, and AME Cloud Ventures.
ABOUT ASIMOV. Asimov programs living cells to create previously impossible biotechnologies. The company’s cell programming platform combines synthetic biology, artificial intelligence, and design automation. Four bioengineering pioneers founded Asimov: Massachusetts Institute of Technology Professor Christopher Voigt, Boston University Professor Douglas Densmore, and MIT Biological Engineering PhDs Alec Nielsen and Raja Srinivas. For more information visit www.asimov.io.